This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Ship, J.A. Articles by Jones, R.E. Search for Related Content PubMed PubMed Citation Articles by Ship, J.A. Articles by Jones, R.E. Social Bookmarking                         What's this?

Parotid Sparing Study in Head and Neck Cancer Patients Receiving Bilateral Radiation Therapy: One-year Results

Department of Oral Medicine, Pathology, Surgery, University of Michigan School of Dentistry, 1011 N. University, Room 2010, Ann Arbor, Michigan 48109-1078

A. Eisbruch

Department of Radiation Oncology, University of Michigan Medical Center, Ann Arbor, Michigan

E. D'Hondt

Department of Oral Medicine, Pathology, Surgery, University of Michigan School of Dentistry, 1011 N. University, Room 2010, Ann Arbor, Michigan 48109-1078

R.E. Jones

Department of Oral Medicine, Pathology, Surgery, University of Michigan School of Dentistry, 1011 N. University, Room 2010, Ann Arbor, Michigan 48109-1078, 0dessa Brown Children's Clinic, Seattle, WA

Many patients with head and neck cancers receive radiation therapy as part of their treatment which frequently causes considerable morbidity, including various degrees of permanent salivary gland dysfunction. Three-dimensional treatment planning [3-DTP] and conformational dose delivery constitute a new therapeutic modality that conforms the high-dose radiation volume to the shape of the tumor volume while minimizing the dose to tissue that is not at risk of containing cancer. The treatment volumes for head and neck tumors as well as parotid glands can be well-defined on cross-sectional CT imaging techniques. The purpose of this investigation is to determine if 3-DTP and conformational dose-delivery could minimize radiation dose and salivary gland dysfunction to contralateral parotid glands in patients with head and neck cancers. Eleven patients with head and neck cancers who required bilateral radiation therapy were treated with 3-DTP. Unstimulated and stimulated bilateral parotid saliva was collected prior to radiotherapy, weekly during treatment, and 1, 3, 6, and 12 months after the completion of radiotherapy. Treated parotid glands received an average dose of 5745 cGy, while spared glands received only 1986 cGy (p < 0.0001). Unstimulated and stimulated parotid flow rates decreased dramatically in treated glands after the initiation of radiotherapy, remained at extremely low rates without any improvements, and were significantly lower at 1 year after radiotherapy compared with baseline. Conversely, parotid flow rates in spared glands underwent mild changes during radiotherapy and were approximately 50% of baseline values. The results of this study suggest that with the use of 3-DTP, contralateral parotid gland function can be partially preserved for at least 1 year in patients with head and neck cancers requiring bilateral radiation.

Key Words: salivary gland function • three-dimensional treatment planning • parotid sparing • head and neck cancer

Journal of Dental Research, Vol. 76, No. 3, 807-813 (1997)
DOI: 10.1177/00220345970760031401


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				C H CLARK, E A MILES, M T G. URBANO, S A BHIDE, A M BIDMEAD, K J HARRINGTON, C M NUTTING, and on behalf of the UK PARSPORT Trial Management Grou Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre Phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancer Br. J. Radiol., July 1, 2009; 82(979): 585 - 594. [Abstract] [Full Text] [PDF]

				M T Guerrero Urbano and C M Nutting Clinical use of intensity-modulated radiotherapy: part I Br. J. Radiol., February 1, 2004; 77(914): 88 - 96. [Abstract] [Full Text] [PDF]

				A.C. O'Connell Natura History an Prevention of Radiation Injury Advances in Dental Research, December 1, 2000; 14(1): 57 - 61. [Abstract] [PDF]